Zollinger-Ellison syndrome secondary prevention: Difference between revisions
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{MJK}} | {{CMG}} {{AE}} {{MJK}} | ||
==Overview== | ==Overview== | ||
Secondary prevention strategies following Zollinger-Ellison syndrome include surgical resection of gastrinoma to prevent malignant trasformation and distant metastasis.<ref name="pmid24319020">{{cite journal| author=Epelboym I, Mazeh H| title=Zollinger-Ellison syndrome: classical considerations and current controversies. | journal=Oncologist | year= 2014 | volume= 19 | issue= 1 | pages= 44-50 | pmid=24319020 | doi=10.1634/theoncologist.2013-0369 | pmc=PMC3903066 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24319020 }} </ref> | Secondary prevention strategies following Zollinger-Ellison syndrome include surgical resection of [[gastrinoma]] to prevent malignant trasformation and distant [[metastasis]].<ref name="pmid24319020">{{cite journal| author=Epelboym I, Mazeh H| title=Zollinger-Ellison syndrome: classical considerations and current controversies. | journal=Oncologist | year= 2014 | volume= 19 | issue= 1 | pages= 44-50 | pmid=24319020 | doi=10.1634/theoncologist.2013-0369 | pmc=PMC3903066 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24319020 }} </ref> | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
Secondary prevention strategies following Zollinger-Ellison syndrome include surgical resection of gastrinoma to prevent malignant trasformation and distant metastasis.<ref name="pmid24319020">{{cite journal| author=Epelboym I, Mazeh H| title=Zollinger-Ellison syndrome: classical considerations and current controversies. | journal=Oncologist | year= 2014 | volume= 19 | issue= 1 | pages= 44-50 | pmid=24319020 | doi=10.1634/theoncologist.2013-0369 | pmc=PMC3903066 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24319020 }} </ref> | Secondary prevention strategies following Zollinger-Ellison syndrome include surgical resection of gastrinoma to prevent malignant trasformation and distant metastasis.<ref name="pmid24319020">{{cite journal| author=Epelboym I, Mazeh H| title=Zollinger-Ellison syndrome: classical considerations and current controversies. | journal=Oncologist | year= 2014 | volume= 19 | issue= 1 | pages= 44-50 | pmid=24319020 | doi=10.1634/theoncologist.2013-0369 | pmc=PMC3903066 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24319020 }} </ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 19:41, 2 October 2015
|
Zollinger-Ellison syndrome Microchapters |
|
Differentiating Zollinger-Ellison syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Zollinger-Ellison syndrome secondary prevention On the Web |
|
American Roentgen Ray Society Images of Zollinger-Ellison syndrome secondary prevention |
|
Risk calculators and risk factors for Zollinger-Ellison syndrome secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Secondary prevention strategies following Zollinger-Ellison syndrome include surgical resection of gastrinoma to prevent malignant trasformation and distant metastasis.[1]
Secondary Prevention
Secondary prevention strategies following Zollinger-Ellison syndrome include surgical resection of gastrinoma to prevent malignant trasformation and distant metastasis.[1]
References
- ↑ 1.0 1.1 Epelboym I, Mazeh H (2014). "Zollinger-Ellison syndrome: classical considerations and current controversies". Oncologist. 19 (1): 44–50. doi:10.1634/theoncologist.2013-0369. PMC 3903066. PMID 24319020.